Skip to main content

Want a detailed portfolio tracker?

VivoSim Labs (VIVS) P/E (2012 - 2026)

VivoSim Labs (VIVS) P/E from Apr 2, 2012 to Jul 21, 2026. The TTM VivoSim Labs (VIVS) P/E is -0.09. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of VivoSim Labs (VIVS)

YearP/EChange
2026-0.09-102.50%
20253.54-794.29%
2024-0.51-1.18%
2023-0.52-104.65%
202211.09-526.30%
2021-2.60-46.62%
2020-4.87+142.20%
2019-2.01-50.03%
2018-4.03+14.75%
2017-3.51-59.75%
2016-8.72+47.98%
2015-5.89-71.84%
2014-20.92-3.64%
2013-21.71+629.83%
2012-2.97N/A

Comparison VivoSim Labs (VIVS) P/E with competitors

VivoSim Labs (VIVS) P/E is -0.09.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-101.92%
NBYStablecoin Development Corp0.00-104.86%
ENLVEnlivex Ltd0.07-184.57%
FGENFibroGen Inc0.24-371.38%
CHRSCoherus Biosciences Inc0.85-1059.33%
FBIOFortress Biotech Inc0.95-1172.95%
ORMPOramed Pharmaceuticals Inc1.50-1799.31%
AGENAgenus Inc3.01-3502.58%
INVAInnoviva Inc3.15-3665.84%
VXRTVaxart Inc3.55-4113.22%
CRMDCorMedix Inc3.63-4202.20%
CVACCureVac N.V.4.45-5126.14%
GLPGGalapagos NV4.86-5593.31%
SRPTSarepta Therapeutics Inc4.88-5619.54%
ABEOAbeona Therapeutics Inc5.39-6190.95%
ABUSArbutus Biopharma Corp5.60-6426.23%
ZVRAZevra Therapeutics Inc5.89-6755.92%
SPROSpero Therapeutics Inc6.23-7141.68%
CGENCompugen Ltd6.31-7238.35%
RIGLRigel Pharmaceuticals6.87-7869.35%
SLXNSilexion Therapeutics Corp7.30-8348.73%
OMEROmeros Corporation9.26-10567.67%
AUPHAurinia Pharmaceuticals Inc9.58-10936.47%
PLXProtalix BioTherapeutics Inc10.89-12413.05%
ACADAcadia Pharmaceuticals Inc11.73-13359.94%
TBPHTheravance Biopharma Inc12.26-13963.24%
ADMAAdma Biologics Inc12.42-14139.61%
HRMYHarmony Biosciences Holdings Inc13.82-15724.73%
SABSSAB Biotherapeutics Inc14.14-16082.01%
NAGENiagen Bioscience Inc14.82-16852.97%
INCYIncyte Corp15.82-17988.56%
REGNRegeneron Pharmaceuticals Inc15.86-18027.11%
PBYIPuma Biotechnology Inc17.32-19676.68%
CPRXCatalyst Pharmaceuticals Inc17.44-19816.42%
EXELExelixis Inc17.54-19928.01%
TGTXTG Therapeutics Inc18.97-21542.53%
MDXGMimedx Group Inc20.55-23336.13%
XOMAXOMA Royalty Corp22.87-25962.21%
ARGXArgen X SE24.30-27571.41%
CTMXCytomX Therapeutics Inc24.82-28162.83%
XOMAOXOMA Royalty Corp25.34-28754.93%
HALOHalozyme Therapeutics Inc25.62-29070.26%
XOMAPXOMA Royalty Corp25.67-29122.72%
VRTXVertex Pharmaceuticals Inc27.99-31750.94%
RPRXRoyalty Pharma plc - Class A28.69-32534.23%
SLNOSoleno Therapeutics Inc29.02-32904.85%
ASNDAscendis Pharma A/S30.09-34114.83%
LGNDLigand Pharmaceuticals Inc - Class B37.91-42963.46%
APLSApellis Pharmaceuticals Inc39.02-44217.53%
BMRNBiomarin Pharmaceutical Inc42.21-47824.87%
KRYSKrystal Biotech Inc45.34-51365.50%
ONCBeiGene Ltd69.54-78722.71%
PHARPharming Group N.V.75.03-84924.24%
TECHBio-Techne Corp101.96-115374.58%
VCELVericel Corp109.92-124377.54%
ALNYAlnylam Pharmaceuticals Inc117.96-133471.85%
GMABGenmab140.29-158713.35%
TLXTelix Pharmaceuticals Ltd162.15-183430.70%
CORTCorcept Therapeutics Inc212.86-240757.64%